hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06359483, orgStudyIdInfo id: 108/2021, briefTitle: The Impact of Meal Frequency on Bone Remodeling in Healthy Adults, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-06-19, primaryCompletionDateStruct date: 2021-07-04, completionDateStruct date: 2021-07-04, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: University of Jordan, class: OTHER, collaborators name: United Arab Emirates University, descriptionModule briefSummary: The study aimed to investigate the effect of meal frequency on bone remodeling using the marker Procollagen Type 1 N-terminal propeptide (P1NP). Thirty healthy adult males from Jordan participated in a randomized controlled intervention trial. They were randomly assigned to three or eight daily meals for three consecutive days over two phases. Blood samples were obtained at the beginning and end of each phase, and P1NP levels were analyzed. The results showed a substantial drop in P1NP levels compared to the baseline, indicating that meal frequency influences bone development. There were no significant changes between the groups eating three and eight meals per day. The study emphasizes the importance of dietary patterns in bone health and advises additional research to understand the relationship between meal frequency and bone metabolism., conditionsModule conditions: Healthy Adults, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ACTUAL, armsInterventionsModule interventions name: Meal Frequency Manipulation, outcomesModule primaryOutcomes measure: The title of the primary outcome is "Procollagen Type 1 N-terminal propeptide (P1NP) Levels.", eligibilityModule sex: ALL, minimumAge: 19 Years, maximumAge: 30 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Jordan, city: Amman, country: Jordan, geoPoint lat: 31.95522, lon: 35.94503, hasResults: False
protocolSection identificationModule nctId: NCT06359470, orgStudyIdInfo id: CaiUni, briefTitle: the Modified Reversed Contralateral Axial Rotation Position, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-11-05, primaryCompletionDateStruct date: 2023-10-01, completionDateStruct date: 2024-01-14, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: Noha Khaled Shoukry, class: OTHER, descriptionModule briefSummary: This study aimed to investigate the effect of specific three-dimensional (3D) positions of the trunk on patients with lumbar discogenic pain with radiculopathy aiming to find a position that directly decompresses the impinged root as well as the effect of this position on the CSA of the L3-L4, L4-L5 and L5-S1 intervertebral foramen (IVF) using 3D-CT scan imaging of the real spine, conditionsModule conditions: Disc Prolapse With Radiculopathy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SEQUENTIAL, interventionModelDescription: This study was conducted on ninety male patients (30 in each group), ages ranged from 20 - 40 years old, and were diagnosed with unilateral lumbar disc prolapse (group1: L3-L4), (group 2: L4- L5) and (group 3: L5-S1) for at least three months in a radiology center specialized in the spine (Egyscan center). Each group was imaged three times (from the supine position, then from the oblique position after 10 minutes, and finally from the oblique position again after 48 hours). The oblique image was taken during a specific trunk position the modified reversed contralateral rotation (side-lying with side bending to the non-affected side and rotation to non affected side).The CSA of LIVF and SLR test was assessed at the three times of testing, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 90, type: ACTUAL, armsInterventionsModule interventions name: Positioning technique, outcomesModule primaryOutcomes measure: Straight leg raising test, secondaryOutcomes measure: Foraminal cross sectional area, eligibilityModule sex: MALE, minimumAge: 20 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: Faculty of Physical Therapy, city: Giza, zip: 12556, country: Egypt, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06359457, orgStudyIdInfo id: P.T.REC/012/005016, briefTitle: Correlation Between Serum Progesterone Level And Primary Dysmenorrhea, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-06, completionDateStruct date: 2024-07, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: This study will be conducted to determine Correlation between the levels of serum progesterone and Menstrual Symptoms In Young Females, conditionsModule conditions: Primary Dysmenorrhea, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Serum progesterone level, primaryOutcomes measure: Pain intensity, primaryOutcomes measure: Physical and psychological symptoms, eligibilityModule sex: FEMALE, minimumAge: 17 Years, maximumAge: 24 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06359405, orgStudyIdInfo id: UBeykentUni, briefTitle: Evaluation of Nursing Students' Crisis Management Skills in Medication Safety Simulation, acronym: RCS, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-20, primaryCompletionDateStruct date: 2024-05-01, completionDateStruct date: 2024-05-02, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: University of Beykent, class: OTHER, descriptionModule briefSummary: This study aims to objectively evaluate student nurses' crisis management skills in drug safety simulation and examine an effective intervention to improve these skills through a randomized controlled study. The research aims to provide important findings that will contribute to the determination of strategies to increase the competencies of student nurses in the fields of drug safety and crisis management.Research Hypotheses:H1: The application of drug safety simulation has an effect on the crisis management skill level of nursing students.The aim of the intervention is to develop a simulation program to enhance nursing students' crisis management skills in drug safety. This simulation program will provide students with the opportunity to recognize, assess, and effectively intervene in medication errors in real-world scenarios.The simulation program will include interactive case scenarios, virtual patients, and simulation sessions led by an instructor providing feedback to students. Additionally, learning materials covering topics such as prevention, recognition, and correction of medication errors will be provided, conditionsModule conditions: Nurse, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: This study was planned as a randomized controlled study to evaluate the crisis management skills of student nurses in drug safety simulation., primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: SINGLE, maskingDescription: The researchers declare that the data obtained from randomly formed groups will be numbered and entered into the statistical analysis program to hide the identity information and that two researchers will be assigned during the entry., whoMasked: PARTICIPANT, enrollmentInfo count: 70, type: ESTIMATED, armsInterventionsModule interventions name: drug safety simulation, outcomesModule primaryOutcomes measure: The effect of drug safety simulation application on the crisis management skill level of nursing students., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06359392, orgStudyIdInfo id: DNZNC466DGR7, secondaryIdInfos id: 1R21NR020383-01, type: NIH, link: https://reporter.nih.gov/quickSearch/1R21NR020383-01, briefTitle: Palliative Care Messaging for American Indians, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-08, primaryCompletionDateStruct date: 2024-05-15, completionDateStruct date: 2024-05-15, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: South Dakota State University, class: OTHER, collaborators name: Great Plains Tribal Leaders Health Board, collaborators name: National Institute of Nursing Research (NINR), descriptionModule briefSummary: The investigators will be conducting a randomized trial in 3 reservation communities to test the efficacy of the narrative as culture-centric health promotion model for increasing American Indian tribal members' palliative care knowledge and intentions to discuss palliative care., conditionsModule conditions: Knowledge, Attitudes, Practice, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 360, type: ESTIMATED, armsInterventionsModule interventions name: No message, interventions name: Culture-centric message, interventions name: General messge, outcomesModule primaryOutcomes measure: Palliative Care Knowledge Scale (PaCKS), primaryOutcomes measure: Knowledge of Care Options (KOCO), primaryOutcomes measure: Hospice and Palliative Care Questionnaire (HPCQ), primaryOutcomes measure: Identification and Transportation with Palliative Care Message, primaryOutcomes measure: Attitudes and Intentions to Discuss Palliative Care, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: South Dakota State University, city: Rapid City, state: South Dakota, zip: 57701, country: United States, contacts name: Mary J Isaacson, PhD, RN, RHNC, CHPN, FPCN, role: CONTACT, phone: 605-670-0975, email: mary.isaacson@sdstate.edu, contacts name: Karla Hunter, PhD, role: CONTACT, phone: 605-212-0894, email: karla.hunter@sdstate.edu, contacts name: Mary J Isaacson, PhD, RN, RHNC, CHPN, FPCN, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 44.08054, lon: -103.23101, hasResults: False
protocolSection identificationModule nctId: NCT06359366, orgStudyIdInfo id: ShenzhenH-guo, briefTitle: Perineal Massage Combined With Hip Joint Training, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-10, primaryCompletionDateStruct date: 2024-07-31, completionDateStruct date: 2024-08-31, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: Shenzhen Hospital of Southern Medical University, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to learn if perineal massage combined with hip joint training works to improve pelvic function (urinary incontinence, constipation and hip motion) in pregnant women. The main questions it aims to answer are:Does the perineal massage combined with hip joint training lower the prevalence of participants who have urinary incontinence and constipation? Does the perineal massage combined with hip joint training improve the flexibility of the hip joint? Researchers will compare an intervention (perineal massage combined with hip joint training) to a comparison(regular training and treatment) to see if the intervention (perineal massage combined with hip joint training) works to improve pelvic function.Participants will:receive the intervention (perineal massage combined with hip joint training ) or regular training and treatment fifth a week at 36 weeks gestation before participants receive first-time intervention, they complete Demographic sociological, ICI-Q-LF, Wexner constipation and hip motion questionnaires, conditionsModule conditions: Pelvic Floor Disorders, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, maskingDescription: when the participants are enrolled in this study, they will be allocated to groups randomly by an independent researcher and sign the consent form. The care providers will not know the outcomes of this study, they just provide treatment for pregnant women; therefore, the care providers could be masked. an independent investigator will send a questionnaire to the participant, and the investigator does not know the intervention participants received; thus they could be masked., whoMasked: CARE_PROVIDER, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 108, type: ESTIMATED, armsInterventionsModule interventions name: perineal massage combined hip joint training, outcomesModule primaryOutcomes measure: pelvic floor function(constipation), primaryOutcomes measure: pelvic floor function (urinary incontinence score), secondaryOutcomes measure: hip motion, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06359353, orgStudyIdInfo id: B-1902-520-004, briefTitle: Effect of Pitavastatin on Bone, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-04-08, primaryCompletionDateStruct date: 2022-02-10, completionDateStruct date: 2023-12-19, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: Seoul National University Bundang Hospital, class: OTHER, collaborators name: JW Pharmaceutical, descriptionModule briefSummary: This clinical trial investigates the effects of pitavastatin on bone health in postmenopausal women with osteopenia or osteoporosis and hypercholesterolemia. Given the high prevalence of osteoporosis in aging populations and the associated risks, even with existing treatments, this study addresses a critical gap in medical research. Statins, specifically HMG-CoA reductase inhibitors, are suggested to benefit bone metabolism by promoting bone formation and reducing resorption. However, the specific impact of pitavastatin on bone metabolism lacks clinical evidence.The study's primary goal is to determine the effects of a 12-month pitavastatin regimen on bone metabolism markers in this population. This research could significantly contribute to developing more effective osteoporosis treatments for postmenopausal women, combining bone health and cholesterol management strategies., conditionsModule conditions: Osteoporosis, Osteopenia, conditions: Hypercholesterolemia, conditions: Menopausal Osteoporosis, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 70, type: ACTUAL, armsInterventionsModule interventions name: Pitavastatin, outcomesModule primaryOutcomes measure: Change in blood urinary N-Telopeptide of Type I Collagen levels compared to baseline after 6 months, secondaryOutcomes measure: Change in blood C-Telopeptide of Type I Collagen levels, secondaryOutcomes measure: Change in blood Osteocalcin levels, secondaryOutcomes measure: Change in urinary N-Telopeptide of Type I Collagen levels, secondaryOutcomes measure: Change in blood Procollagen Type 1 N-Terminal Propeptide levels, secondaryOutcomes measure: Change in blood LDL-cholesterol levels, secondaryOutcomes measure: Change in blood HbA1c levels, secondaryOutcomes measure: Changes in bone mineral density, otherOutcomes measure: Changes of the outcomes after 12 months, eligibilityModule sex: FEMALE, maximumAge: 75 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Seoul National University Bundang Hospital, city: Seongnam, state: Gyeonggi, zip: 463-707, country: Korea, Republic of, geoPoint lat: 37.43861, lon: 127.13778, hasResults: False
protocolSection identificationModule nctId: NCT06359327, orgStudyIdInfo id: Pro00075623, briefTitle: Effect of Consumption of Pep19 on Quality of Life, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-17, primaryCompletionDateStruct date: 2024-07-17, completionDateStruct date: 2024-08-15, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: Proteimax Biotechnology Israel LTD, class: INDUSTRY, descriptionModule briefSummary: Pep19 is a naturally occurring peptide (protein) that triggers loss of body fat. It has been certified Generally Recognized as Safe (GRAS) at up to 3.8 grams per day and may be included in various foods. Pep19 has no effect on the brain, heart, pancreas or skeletal muscle. It is highly purified, not allergenic or mutagenic, and free of microbes, metals and other contaminants. Preliminary, open-label, uncontrolled studies have shown that Pep19 is well tolerated in rodents, dogs, and humans. This placebo-controlled study will evaluate the effects of two doses of Pep19™ -- 2 mg and 5 mg - on quality of life and sleep quality in obese subjects., conditionsModule conditions: Quality of Life, conditions: Obesity, conditions: Sleep Quality, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 24, type: ESTIMATED, armsInterventionsModule interventions name: Placebo, interventions name: Pep19 2 mg, interventions name: Pep19 5 mg, outcomesModule primaryOutcomes measure: Improvement on QoL, primaryOutcomes measure: Improvement on Sleep quality, secondaryOutcomes measure: Temperature, secondaryOutcomes measure: Blood pressure, secondaryOutcomes measure: Heart rate, secondaryOutcomes measure: circumference, secondaryOutcomes measure: blood tests, secondaryOutcomes measure: Body fat, secondaryOutcomes measure: Body weight, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Precision Clinical Research, LLC, status: RECRUITING, city: Sunrise, state: Florida, zip: 33351, country: United States, contacts name: Jason Haffizulla, MD, role: CONTACT, geoPoint lat: 26.13397, lon: -80.1131, hasResults: False
protocolSection identificationModule nctId: NCT06359314, orgStudyIdInfo id: STU00219362, briefTitle: Anxiety Lowering and Deprescribing Through Emotion Regulation, acronym: ALDER, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-07, completionDateStruct date: 2024-07, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: Northwestern University, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to test ALDER (Anxiety Lowering and Deprescribing through Emotion Regulation), an online self-guided positive emotion intervention, in patients over the age of 65 who are candidates for benzodiazepine receptor agonist (BZRA, commonly called benzos, or z-drugs) deprescribing. The main questions it aims to answer are:* Is ALDER relevant to and satisfactory for older adult BZRA users?* Does ALDER help to increase positive emotions and decrease anxiety, trouble sleeping, and use of BZRA medications?Participants will complete the 5-week online self-guided ALDER intervention as well as two survey assessments, one before the intervention and one after., conditionsModule conditions: Benzodiazepine Dependence, conditions: Anxiety Disorders, conditions: Sleep Disturbance, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: ALDER, outcomesModule primaryOutcomes measure: Feasibility of intervention, primaryOutcomes measure: Acceptability of intervention, primaryOutcomes measure: Adoption of intervention, secondaryOutcomes measure: Patient benzodiazepine receptor agonist (BZRA) use, secondaryOutcomes measure: Patient attitude towards deprescribing BZRAs, secondaryOutcomes measure: Patient-reported sleep disturbance, secondaryOutcomes measure: Patient-reported anxiety, secondaryOutcomes measure: Patient-reported stress, secondaryOutcomes measure: Patient-reported depression, secondaryOutcomes measure: Patient-reported positive affect, secondaryOutcomes measure: Patient-reported meaning and purpose, secondaryOutcomes measure: Patient-reported comorbidities, eligibilityModule sex: ALL, minimumAge: 65 Years, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06359301, orgStudyIdInfo id: H-34, briefTitle: H-34 DELTA Revision Cup, statusModule overallStatus: RECRUITING, startDateStruct date: 2021-09-14, primaryCompletionDateStruct date: 2026-03-31, completionDateStruct date: 2029-03-31, studyFirstPostDateStruct date: 2024-04-11, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: Limacorporate S.p.a, class: INDUSTRY, descriptionModule briefSummary: THis study is aimed to provide a clinical and radiographic evaluation of 49 suitable subjects who underwent a total hip arthroplasty with DELTA Revision acetabular cup., conditionsModule conditions: Hip, Osteoarthritis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 49, type: ESTIMATED, armsInterventionsModule interventions name: DELTA Revision acetabular cup, outcomesModule primaryOutcomes measure: Harris Hip Score (HHS), secondaryOutcomes measure: ROM measurement, secondaryOutcomes measure: Oxforn Hip Score (OHS), secondaryOutcomes measure: Survival rate, secondaryOutcomes measure: Radiographic implant evaluation and stability assessment of the DELTA Revision acetabular cup, secondaryOutcomes measure: Incidence, type and severity of all the Adverse Events (AEs), Serious Adverse Events (SAEs), Adverse Device Effects (ADEs), and Serious Adverse Device Effects (SADEs) occurred at each follow-up, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP, status: RECRUITING, city: Otwock, zip: 05-400, country: Poland, contacts name: Jerzy Bialecki, role: CONTACT, geoPoint lat: 52.10577, lon: 21.26129, hasResults: False